Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Zbigniew Mrowiec"'
Autor:
Manoochehr Khorshidi, Zbigniew Mrowiec, Leslie Oleksowicz, Janice P. Dutcher, E G Puszkin, Edward L. Schwartz
Publikováno v:
Thrombosis Research. 79:261-274
Tumor cell induced platelet aggregation is thought to be an early step in the metastatic process. Here we show that platelet aggregation induced by MCF-7 cells is mediated, in part, through an ADP-dependent mechanism based on inhibition of aggregatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::711a37f10526bf22a947d9f44bdb088f
https://doi.org/10.1016/0049-3848(95)00113-6
https://doi.org/10.1016/0049-3848(95)00113-6
Publikováno v:
Thrombosis and Haemostasis. 72:302-308
SummaryThe effect of IL-6 on in vitro platelet function was investigated. Platelet-rich plasma (PRP) incubated with IL-6 showed a dose dependent enhancement of agonist induced maximum aggregation (AIMA) and secretion of thromboxane B2 (TXB2) as measu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26c929608f2ea70885d21310802b4343
https://doi.org/10.1055/s-0038-1648857
https://doi.org/10.1055/s-0038-1648857
Apyrase, ascorbic acid and aprotinin ameliorate the storage lesion in pelleted platelet preparations
Autor:
P. Lalezari, De Leon-Fernandez M, Leslie Oleksowicz, Janice P. Dutcher, E G Puszkin, Zbigniew Mrowiec
Publikováno v:
Biotechnichistochemistry : official publication of the Biological Stain Commission. 72(5)
To evaluate the effect of apyrase, ascorbic acid and aprotinin (AAA) in preventing platelet activation during storage, 12 sets of platelet concentrates (PCs), were treated with AAA and evaluated at days 1, 3, and 5 utilizing platelet functional and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5746c07c251058bc84565fac1548ec9
https://pubmed.ncbi.nlm.nih.gov/9408586
https://pubmed.ncbi.nlm.nih.gov/9408586
Autor:
M Khorshidi, D Zuckerman, M. De Leon-Fernandez, E G Puszkin, Leslie Oleksowicz, Zbigniew Mrowiec, Janice P. Dutcher
Publikováno v:
Transfusion. 36(1)
Background: Platelet activation is an important factor impeding the clinical effectiveness of platelet transfusions. In this study, platelet concentrates (PCs) were prepared by a novel suspended-bag buffy coat technique that was followed by the addit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a98e0ab026b9e4a80e649593b01567ee
https://pubmed.ncbi.nlm.nih.gov/8607153
https://pubmed.ncbi.nlm.nih.gov/8607153
Publikováno v:
Cancer investigation. 14(4)
Platelet function in 12 cancer patients was studied sequentially over 97 hr of interleukin-6 (IL-6) daily bolus or continuous infusion (C.I.) therapy. During this period, enhanced ex vivo agonist-induced platelet maximum aggregation (MA) was parallel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e549c1a223d5967b40ff82375ee2eeb
https://pubmed.ncbi.nlm.nih.gov/8689424
https://pubmed.ncbi.nlm.nih.gov/8689424
Publikováno v:
American journal of hematology. 48(2)
The in vitro effect of IL-6 on platelet activation was investigated. When human platelets were incubated with high (1,000 ng/ml) or low (1 ng/ml) dose IL-6, expression of GMP-140 was enhanced by 42% (N = 6; P < 0.009) and 46% (N = 6; P < 0.061) in 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c689066c56cecf3359ba7a85e26b16b2
https://pubmed.ncbi.nlm.nih.gov/7531395
https://pubmed.ncbi.nlm.nih.gov/7531395
Publikováno v:
American journal of hematology. 45(3)
Platelet function in 16 patients with metastatic renal cell carcinoma and melanoma was studied sequentially over the first 96 hr of treatment with moderate and high-dose interleukin-2 (IL-2). During the first 96 hr of therapy, an increased ex vivo pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e78a7fc7b542e96bea9a1912d0db37da
https://pubmed.ncbi.nlm.nih.gov/8296793
https://pubmed.ncbi.nlm.nih.gov/8296793